GL
NYSE Globe Life Inc.$166.08 ↑ +0.00 (+0.00%) Trading Up from the previous close of $166.08, $0.47 below the day’s high of $166.56
- YTD change
- +18.75%
- vs 20-day SMA
- -3.10%
- vs 200-day SMA
- +5.89%
Price ranges
Price & Performance
+29.63 (+21.71%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 13.3% away from all-time highs of $191.55
- GL is up 19% since the beginning of the year
- GL is up 16% over the past 12 months
- GL is down 4% over the past 1 month
- 3% of all GL investors are betting against GL
- Number of investors short GL has gone up 28% versus last month
GL reads not so good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is +15.7%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -3.53%
- vs 8-day SMA
- -2.10%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Globe Life, Inc. is an insurance holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Health Insurance, and Investments Insurance. The Life Insurance segment offers products marketed by Globe Life include traditional whole life and term life insurance. The Health Insurance segment is involved in the renewable and includes Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products. The Investments Insurance segment refers to the management of capital resources, including investments, and the management of liquidity. The company was founded on November 19, 1979, and is headquartered in McKinney, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
